D
PTC Therapeutics, Inc. PTCT
$50.41 -$0.16-0.32% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -107.48% 1,415.24% 38.22% -7.54% -8.30%
Total Depreciation and Amortization 5.01% 6.76% 4.29% -7.58% -87.33%
Total Amortization of Deferred Charges 1.00% -2.61% 2.33% 1.69% -0.34%
Total Other Non-Cash Items -59.71% 590.50% -159.55% -58.71% -23.20%
Change in Net Operating Assets 60.27% -215.04% 272.04% 187.96% -117.06%
Cash from Operations -106.70% 2,999.96% 61.03% -7.75% -200.98%
Capital Expenditure 23.61% 54.23% -621.65% -107.08% 176.92%
Sale of Property, Plant, and Equipment -100.00% -- -100.00% -99.94% --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -130.26% -167.30% 743.76% 58.38% 3.80%
Cash from Investing -128.90% -168.87% 727.33% 35.27% 42.64%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- 100.00%
Issuance of Common Stock -74.85% -40.50% 4,519.72% -87.78% 131.03%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 100.00% -- 100.00% -107.53% --
Cash from Financing -57.91% -64.45% 250.17% -107.15% 45,544.81%
Foreign Exchange rate Adjustments 151.96% 162.33% -201.30% 264.68% -155.52%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -166.06% 174.16% 298.46% -223.90% 327.59%